STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2802 by analyst upside · 2026-08-13
NEOG
Neogen Corporation
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+13.4%
implied upside to consensus target
Current Price $11.46
Consensus Target $13.0
Bull Target $14.0
Bear Target $12.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
1
Hold
2
Sell
0
52-Week Low $4.9
52-Week High $12.85
YTD Return +63.7%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 30.2x
EPS (TTM) $-0.04
PEG Ratio 0.66
Dividend Yield N/A
Revenue (TTM) $870M
Profit Margin -0.9%
52-WEEK RANGE
52-Week Low $4.9
52-Week High $12.85
Current Price $11.46
Bear Target $12.0
Bull Target $14.0
● Now $11.46 ● Target $13.0
TRADING DATA
Avg Volume 2.4M
YTD Return +63.7%
Analyst Count 3
Consensus Buy
Upside to Target +13.4%
Last Updated 2026-08-13

ANALYST SUMMARY

Neogen Corporation (NEOG) is currently trading at $11.46 with a Wall Street consensus price target of $13.0, implying potential upside of 13.4% over the next 12 months. 3 analysts currently cover NEOG, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $12.0.

NEOG operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 63.7% year-to-date and is currently trading near the upper end of its 52-week range of $4.9 – $12.85.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NEOG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Piper Sandler reit
Neutral → Neutral 2026-01-12 14% win rate (7 calls)
Guggenheim - Reiterated
Buy → Buy 2026-01-09 62% win rate (8 calls)
CJS Securities ↑ Upgrade
Market Perform → Market Outperform 2025-12-10 Building track record
Piper Sandler reit
Neutral → Neutral 2025-10-16 14% win rate (7 calls)
CJS Securities ● Initiated
Market Perform 2025-09-29 Building track record
William Blair ↓ Downgrade
Outperform → Market Perform 2025-07-29 44% win rate (9 calls)
Guggenheim - Reiterated
Buy → Buy 2025-06-30 62% win rate (8 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2025-04-22 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
11/30
Consensus clarity
27/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →